Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Zappia

Showing results (1-10 of 295) with videos related to

Pageof 30
Sort By:
Neurology|December 25, 2002
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamicsMario Zappia, Aldo Quattrone
Movement Disorders : Official Journal of the Movement Disorder Society|November 13, 2007
Continuous dopaminergic stimulation: is it the answer to the motor complications of levodopa?Mario Zappia, Aldo Quattrone
Journal of Neurology|November 17, 2010
The role of the long-duration response to levodopa in Parkinson's diseaseMario Zappia, Alessandra Nicoletti
Movement Disorders : Official Journal of the Movement Disorder Society|January 16, 2016
Coffee consumption and risk of levodopa-induced dyskinesia in Parkinson's disease: The FRAGAMP studyAlessandra Nicoletti, Mario Zappia,
Journal of Neurology|January 21, 2021
Letter to the editors: comment on "Emerging themes in idiopathic intracranial hypertension"Simona Toscano, Mario Zappia
Neurology|March 13, 2002
Association study of dopamine D2, D3 receptor gene polymorphisms with motor fluctuations in PDMario Zappia, Grazia Annesi, Aldo Quattrone
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 15, 2024
Acute ataxic neuropathy due to Bartonella infection: a rare variant for a rare associationGiorgia Sciacca, Angelo Battiato, Mario Zappia
Movement Disorders : Official Journal of the Movement Disorder Society|September 20, 2021
Neuroticism and Risk of Parkinson's Disease: A Meta-AnalysisAntonina Luca, Alessandra Nicoletti, Mario Zappia
Frontiers in Neurology|October 4, 2024
Simple biomarkers to distinguish Parkinson's disease from its mimics in clinical practice: a comprehensive review and future directionsAndrea Quattrone, Mario Zappia, Aldo Quattrone
BMC Neurology|December 9, 2015
Clinical and radiologic rebound after discontinuation of natalizumab therapy in a highly active multiple sclerosis patient was not halted by dimethyl-fumarate: a case reportFrancesco Patti, Carmela Leone, Mario Zappia
Pageof 30

Showing results (1-10 of 295) with videos related to

Sort By:
Pageof 30
Neurology|December 25, 2002
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamicsMario Zappia, Aldo Quattrone
Movement Disorders : Official Journal of the Movement Disorder Society|November 13, 2007
Continuous dopaminergic stimulation: is it the answer to the motor complications of levodopa?Mario Zappia, Aldo Quattrone
Journal of Neurology|November 17, 2010
The role of the long-duration response to levodopa in Parkinson's diseaseMario Zappia, Alessandra Nicoletti
Movement Disorders : Official Journal of the Movement Disorder Society|January 16, 2016
Coffee consumption and risk of levodopa-induced dyskinesia in Parkinson's disease: The FRAGAMP studyAlessandra Nicoletti, Mario Zappia,
Journal of Neurology|January 21, 2021
Letter to the editors: comment on "Emerging themes in idiopathic intracranial hypertension"Simona Toscano, Mario Zappia
Neurology|March 13, 2002
Association study of dopamine D2, D3 receptor gene polymorphisms with motor fluctuations in PDMario Zappia, Grazia Annesi, Aldo Quattrone
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 15, 2024
Acute ataxic neuropathy due to Bartonella infection: a rare variant for a rare associationGiorgia Sciacca, Angelo Battiato, Mario Zappia
Movement Disorders : Official Journal of the Movement Disorder Society|September 20, 2021
Neuroticism and Risk of Parkinson's Disease: A Meta-AnalysisAntonina Luca, Alessandra Nicoletti, Mario Zappia
Frontiers in Neurology|October 4, 2024
Simple biomarkers to distinguish Parkinson's disease from its mimics in clinical practice: a comprehensive review and future directionsAndrea Quattrone, Mario Zappia, Aldo Quattrone
BMC Neurology|December 9, 2015
Clinical and radiologic rebound after discontinuation of natalizumab therapy in a highly active multiple sclerosis patient was not halted by dimethyl-fumarate: a case reportFrancesco Patti, Carmela Leone, Mario Zappia
Pageof 30